Lidia Ostanek

415 total citations
39 papers, 296 citations indexed

About

Lidia Ostanek is a scholar working on Rheumatology, Immunology and Molecular Biology. According to data from OpenAlex, Lidia Ostanek has authored 39 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Rheumatology, 13 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Lidia Ostanek's work include Systemic Lupus Erythematosus Research (23 papers), Systemic Sclerosis and Related Diseases (7 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Lidia Ostanek is often cited by papers focused on Systemic Lupus Erythematosus Research (23 papers), Systemic Sclerosis and Related Diseases (7 papers) and Atherosclerosis and Cardiovascular Diseases (5 papers). Lidia Ostanek collaborates with scholars based in Poland, United States and Czechia. Lidia Ostanek's co-authors include Marek Brzosko, Iwona Brzosko, Andrzej Pawlik, Marek Masiuk, Bogusław Machaliński, B Gawrońska-Szklarz, Katarzyna Fischer, Krystyna Honczarenko, Marcin Florczak and Andrzej Ciechanowicz and has published in prestigious journals such as Annals of the Rheumatic Diseases, Clinical Pharmacology & Therapeutics and Lara D. Veeken.

In The Last Decade

Lidia Ostanek

36 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lidia Ostanek Poland 9 154 139 47 35 32 39 296
Iwona Brzosko Poland 8 146 0.9× 125 0.9× 39 0.8× 30 0.9× 28 0.9× 28 276
Emma MacDermott Ireland 7 166 1.1× 164 1.2× 64 1.4× 27 0.8× 28 0.9× 18 334
Izumi Kurata Japan 10 107 0.7× 119 0.9× 41 0.9× 23 0.7× 29 0.9× 19 268
Gry B. N. Nordang Norway 9 82 0.5× 166 1.2× 55 1.2× 43 1.2× 25 0.8× 9 330
Alicia Eimon Argentina 9 186 1.2× 170 1.2× 51 1.1× 18 0.5× 15 0.5× 14 317
Iván Posso‐Osorio Colombia 11 150 1.0× 112 0.8× 52 1.1× 32 0.9× 28 0.9× 55 326
Francesca Miranda Italy 11 213 1.4× 140 1.0× 63 1.3× 24 0.7× 15 0.5× 19 323
Junji Kamogawa Japan 12 104 0.7× 132 0.9× 72 1.5× 15 0.4× 19 0.6× 17 337
TRDJ Radstake Netherlands 10 118 0.8× 97 0.7× 43 0.9× 47 1.3× 11 0.3× 20 268
Ornella J. Rullo United States 5 174 1.1× 148 1.1× 42 0.9× 13 0.4× 15 0.5× 6 237

Countries citing papers authored by Lidia Ostanek

Since Specialization
Citations

This map shows the geographic impact of Lidia Ostanek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lidia Ostanek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lidia Ostanek more than expected).

Fields of papers citing papers by Lidia Ostanek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lidia Ostanek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lidia Ostanek. The network helps show where Lidia Ostanek may publish in the future.

Co-authorship network of co-authors of Lidia Ostanek

This figure shows the co-authorship network connecting the top 25 collaborators of Lidia Ostanek. A scholar is included among the top collaborators of Lidia Ostanek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lidia Ostanek. Lidia Ostanek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ostanek, Lidia, Agnieszka Bińczak‐Kuleta, Katarzyna Fischer, et al.. (2014). PTPN22 1858C>T gene polymorphism in patients with SLE: association with serological and clinical results. Molecular Biology Reports. 41(9). 6195–6200. 17 indexed citations
3.
Ostanek, Lidia, et al.. (2014). Selected principles of proper education of women with rheumatic diseases in respect of pregnancy planning. Reumatologia/Rheumatology. 52(1). 49–56. 2 indexed citations
4.
Modrzejewska, Monika, et al.. (2013). Ocular manifestations in a newborn from a pregnancy complicated by an antiphospholipid syndrome – a case report. Ginekologia Polska. 84(10). 888–91. 1 indexed citations
5.
Ostanek, Lidia, et al.. (2012). Polymorphism of C1q complement (rs292001) occurrence in systemic lupus erythematosus patients. Postępy Nauk Medycznych. 1 indexed citations
6.
Clark, Jeremy S. C., Lidia Ostanek, Mariusz Kaczmarczyk, et al.. (2011). The distribution of human endogenous retrovirus K-113 in health and autoimmune diseases in Poland. Lara D. Veeken. 50(7). 1310–1314. 19 indexed citations
7.
Honczarenko, Krystyna, et al.. (2009). Neurological syndromes in systemic lupus erythematosus and their association with antiphospholipid syndrome.. PubMed. 42(6). 513–7. 19 indexed citations
8.
Ostanek, Lidia, et al.. (2006). Case report Coexistence of Wegener’s granulomatosis and systemic lupus erythmatosus – presentation of case with diagnosis for discussion. Reumatologia/Rheumatology. 44(6). 364–368.
9.
Ostanek, Lidia, et al.. (2006). [Severe neurological and obstetrical complications in a patient with antiphospholipid syndrome].. PubMed. 115(5). 457–62. 1 indexed citations
10.
Ostanek, Lidia, et al.. (2006). Fungal spondylodiscitis in a patient with ulcerative colitis - case report.. PubMed. 8(6). 708–13. 2 indexed citations
11.
Ostanek, Lidia, Marek Brzosko, & Katarzyna Fischer. (2005). ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPER Usefullness different antiphospholipid antibodies in the assessment of the secondary antiphospholipid syndrome in lupus erythematosus patients – review and own experiences. Reumatologia/Rheumatology. 43(6). 354–357. 1 indexed citations
12.
Ostanek, Lidia, et al.. (2005). ARTYKUŁ PRZEGLĄDOWY/REVIEW PAPER Cardiovascular system involvement in systemic lupus erythematosus – review and own observations. Serological risk factor of cardiological complications. Reumatologia/Rheumatology. 43(6). 373–378. 1 indexed citations
13.
Pawlik, Andrzej, et al.. (2005). TNF-alpha -308 promoter polymorphism in patients with rheumatoid arthritis.. PubMed. 34(1). 22–6. 25 indexed citations
14.
Fischer, Katarzyna, et al.. (2004). Value of high resistance index - HRI calculated from Doppler spectrum of popliteal arteries in patients with systemic lupus erythematosus (SLE).. PubMed. 10 Suppl 3. 58–62. 5 indexed citations
15.
Brzosko, Iwona, Marek Brzosko, Marek Droździk, et al.. (2004). The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab. Clinical Rheumatology. 23(3). 214–217. 7 indexed citations
16.
Pawlik, Andrzej, et al.. (2004). The influence of N-acetyltransferase 2 polymorphism on rheumatoid arthritis activity.. PubMed. 22(1). 99–102. 3 indexed citations
17.
Pawlik, Andrzej, Lidia Ostanek, Iwona Brzosko, et al.. (2003). The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis. Arthritis Research & Therapy. 5(4). R210–3. 96 indexed citations
18.
Pawlik, Andrzej, Lidia Ostanek, Iwona Brzosko, et al.. (2003). Therapy with infliximab decreases the CD4+CD28? T cell compartment in peripheral blood in patients with rheumatoid arthritis. Rheumatology International. 24(6). 351–354. 18 indexed citations
19.
Pawlik, Andrzej, et al.. (2002). Increased genotype frequency of N‐acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis. Clinical Pharmacology & Therapeutics. 72(3). 319–325. 14 indexed citations
20.
Ostanek, Lidia, et al.. (2000). [Antiphospholipid antibodies in high-risk pregnancy].. PubMed. 71(6). 500–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026